88 high_pathogenic_count
BRCA2 BayesDel gene-specific calibration: high_pathogenic_count
- Tested configuration
- BayesDel with ENIGMA BRCA gene-specific score categories
- Protocol
- BRCA2 BayesDel evidence calibration
- Dataset
- BRCA2 functional reference calibration set
- Related family profiles
- BayesDel
- Procedure
- Not reported
- Evaluation
- BRCA2 BayesDel gene-specific calibration
- Coverage
- scored: unreported; eligible: unreported
- Uncertainty
- Not reported
- Evidence
- Author-reported evaluation · source checkedEvidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, pathogenic_count
A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.
Reproduction
- Split
- Not reported
- Adaptation
- Not reported
- Scoring implementation
- Source-defined endpoint; see result source_locator
No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.
Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
1 evidence row matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Reported result 88 Individual claims | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel Table 2, BRCA2, BayesDel ≥0.30, pathogenic_count Version: 2024 final article; reported VCEP specifications v1.0 | source checked automated source review · 2026-09-30 author reported Audit detailsTranscription from inspected primary source. No execution, independent replication or human scientific review. Field: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
View linked audit checks and correction history
Release 2026-09-30-e37e3ab1284d · Record review: source checked
1 source records and release history
- Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Original source · 2024 final article; reported VCEP specifications v1.0
Technical metadata and extraction receipts
Stable ID: uc-clinical-20260930-enigma-brca2-high-pathogenic-count
- areas
- dna-genomes
- contexts
- clinical_research
- metric
- high_pathogenic_count
- unit
- count
- printed value
- 88
- numeric value
- 88
- metric direction
- unknown
- uncertainty
- Not reported
- source locator
- Table 2, BRCA2, BayesDel ≥0.30, pathogenic_count
- review
- method: automated_source_review; reviewer: Codex clinical coverage worker; date: 2026-09-30; note: Transcription from inspected primary source. No execution, independent replication or human scientific review.; source id: uc-clinical-20260930-source-enigma
- score category
- ≥0.30
- denominator
- 134
- missing metadata
- uncertainty: not reported for this endpoint
Related records
- evaluation: BRCA2 BayesDel gene-specific calibration